ImmunoPrecise Antibodies ... (IPA)
NASDAQ: IPA
· Real-Time Price · USD
0.85
0.15 (21.17%)
At close: Jun 16, 2025, 3:59 PM
0.82
-3.54%
After-hours: Jun 16, 2025, 07:55 PM EDT
21.17% (1D)
| Bid | 0.74 |
| Market Cap | 38.9M |
| Revenue (ttm) | 24M |
| Net Income (ttm) | -46.12M |
| EPS (ttm) | -1.23 |
| PE Ratio (ttm) | -0.69 |
| Forward PE | -6.38 |
| Analyst | Buy |
| Ask | 0.84 |
| Volume | 3,049,686 |
| Avg. Volume (20D) | 1,639,785 |
| Open | 0.71 |
| Previous Close | 0.70 |
| Day's Range | 0.70 - 0.85 |
| 52-Week Range | 0.27 - 1.08 |
| Beta | 0.22 |
Analyst Forecast
According to 0 analyst ratings, the average rating for IPA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
ImmunoPrecise Antibodies Ltd. is scheduled to release its earnings on Jul 28, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
5 days ago
+21.57%
ImmunoPrecise Antibodies shares are trading higher...
Unlock content with
Pro Subscription
1 week ago
+22.38%
ImmunoPrecise Antibodies shares are trading higher after the company announced it discovered a highly conserved epitope across all four dengue virus serotypes using its proprietary LENSai platform
2 months ago · seekingalpha.com
ImmunoPrecise Antibodies Ltd. (IPA) Q3 2025 Earnings Call TranscriptImmunoPrecise Antibodies Ltd. (NASDAQ:IPA ) Q3 2025 Earnings Conference Call March 28, 2025 10:30 AM ET Company Participants Jennifer Bath - Chief Executive Officer and President Joseph Scheffler - In...
